Retraction: Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up (Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology (2021) 40 4 (152-157))
Amir Dori, Michela Guglieri, Marianna Scutifero, Luigia Passamano, Antonio Trabacca, Luisa Politano
Research output: Contribution to journal › Comment/debate
Fingerprint
Dive into the research topics of 'Retraction: Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up (Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology (2021) 40 4 (152-157))'. Together they form a unique fingerprint.